Wariki Windy Mariane Virenia, Ota Erika, Mori Rintaro, Wiysonge Charles S, Horvath Hacsi, Read Jennifer S
Faculty of Medicine, Sam Ratulangi University, Manado, Indonesia.
Graduate School of Nursing Science, Global Health Nursing, St. Luke's International University, Tokyo, Japan.
BMJ Open. 2017 Jun 21;7(6):e014332. doi: 10.1136/bmjopen-2016-014332.
Various interventions to prevent mother-to-child-transmission (MTCT) of HIV have been investigated and implemented. A number of systematic reviews assessing the efficacy of interventions for the prevention of MTCT of HIV reported antiretroviral prophylaxis, caesarean section before labour and before ruptured membranes, and complete avoidance of breastfeeding were efficacious for preventing MTCT of HIV. Recent WHO guidelines recommend lifelong antiretroviral therapy for all pregnant women for treatment of the woman's own HIV infection and for prevention of MTCT of HIV. Therefore, the objective of this overview is to evaluate the currently available systematic reviews of interventions for preventing MTCT of HIV, and to identify the current best evidence-based interventions for reducing the risk of MTCT of HIV.
We will include only peer-reviewed systematic reviews of randomised or quasi-randomised controlled trials assessing the effects of interventions for preventing MTCT of HIV that target both HIV-infected women and children aged 2 years and younger born to HIV-infected women. We will search the Cochrane Database of Systematic Reviews, the Database of Abstracts of Reviews of Effectiveness, Ovid MEDLINE and EMBASE. We will assess review eligibility, the methodological quality of included systematic reviews using A Measurement Tool to Assess The Systematic Reviews and will extract data, comparing our results and resolving discrepancies by consensus. Finally, we will independently assess the certainty of the evidence using Grades of Recommendation, Assessment, Development and Evaluation.
Ethics approval is not required. We will publish the results in a peer-reviewed journal and present at conferences, which will inform future research and will be useful for healthcare managers, administrators and policymakers to guide resource allocation decisions and optimisation of interventions to prevent the MTCT of HIV.
为预防艾滋病毒母婴传播(MTCT),人们已对多种干预措施展开研究并付诸实施。多项评估艾滋病毒母婴传播预防干预措施疗效的系统评价报告称,抗逆转录病毒药物预防、临产前及胎膜破裂前剖宫产以及完全避免母乳喂养对预防艾滋病毒母婴传播有效。世界卫生组织最近的指南建议,所有孕妇接受终身抗逆转录病毒治疗,以治疗孕妇自身的艾滋病毒感染并预防艾滋病毒母婴传播。因此,本综述的目的是评估目前关于预防艾滋病毒母婴传播干预措施的系统评价,并确定当前基于最佳证据的降低艾滋病毒母婴传播风险的干预措施。
我们将仅纳入针对艾滋病毒感染妇女及这些妇女所生2岁及以下儿童预防艾滋病毒母婴传播干预措施效果评估的随机或半随机对照试验的同行评审系统评价。我们将检索Cochrane系统评价数据库、效果评价文摘数据库、Ovid MEDLINE和EMBASE。我们将评估评价的合格性,使用系统评价评估测量工具评估纳入系统评价的方法学质量,并提取数据,比较我们的结果并通过共识解决差异。最后,我们将使用推荐分级、评估、制定与评价独立评估证据的确定性。
无需伦理批准。我们将在同行评审期刊上发表结果,并在会议上展示,这将为未来研究提供信息,对医疗保健管理人员、行政人员和政策制定者指导资源分配决策以及优化预防艾滋病毒母婴传播的干预措施有用。